Last checked at 16 Mar 2022 07:00
16 March 2022
Oncimmune Holdings plc
("Oncimmune" or the "Company")
Block Listing Six Monthly Return
Oncimmune makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements in respect of Oncimmune Holdings plc 2016 Unapproved and EMI Share Option Plans (the "Share Option Plans").
Name of applicant: | Oncimmune Holdings plc
|
Name of scheme: | Oncimmune Holdings plc 2016 Unapproved and EMI Share Option Plans
|
Period of return: | 16 September 2021 to 15 March 2022
|
Balance of unallotted securities under scheme(s) from previous return:
| 5,805,745 |
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
| 0 |
Less: Number of securities issued/allotted under scheme(s) during period:
| 18,399 |
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
| 5,787,346 |
For further information:
Oncimmune Holdings plc
Ron Kirschner, Company Secretary
contact@oncimmune.co.uk
Singer Capital Markets (Nominated Adviser and Joint Broker)
Aubrey Powell, Harry Gooden, George Tzimas, James Fischer
+44 (0)20 7496 3000
WG Partners (Joint Broker)
David Wilson, Nigel Barnes, Erland Sternby
+44 (0)20 3705 9321
Media enquiries:
FTI Consulting
Ben Atwell, Michael Trace, Alex Davis
Oncimmune@fticonsulting.com
+44 (0)20 3727 1000